Skip to main content

Institutional Biosafety Committee

IBC Meeting

The University of Maryland Institutional Biosafety Committee was created as a requirement under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), which states that "Each institution conducting or sponsoring recombinant DNA research which is covered by the NIH Guidelines is responsible for ensuring that the research is conducted in full conformity with the provisions of the NIH Guidelines. In order to fulfill this responsibility, the institution shall: ... establish an Institutional Biosafety Committee..." The policy of the committee is to work cooperatively with researchers, faculty and staff while assuring compliance with the NIH Guidelines.

The responsibilities of the IBC are derived from those listed in the NIH Guidelines:

  • Reviewing recombinant DNA research conducted at or sponsored by the institution for compliance with the NIH Guidelines and approving those research projects that are found to conform to the NIH Guidelines,
  • Notifying the PI of the results of the IBC's review and approval,
  • Lowering containment levels for certain experiments as specified in Section III-D-2-a of the NIH Guidelines,
  • Setting containment levels that are not set by the NIH Guidelines,
  • Periodically reviewing recombinant DNA research conducted at the institution to ensure compliance with the NIH Guidelines,
  • Adopting emergency plans covering accidental spills and personnel contamination resulting from recombinant DNA research,
  • Reporting any significant problems with or violations of the NIH Guidelines and any significant research related accidents or illnesses to the appropriate institutional official and to the NIH Office of Biotechnology Activities (OBA) within 30 days, and
  • Performing such other functions as may be delegated to the IBC, including review of non-recombinant human pathogens and Select Agents and Toxins according to the current edition of the NIH/CDC publication Biosafety in Microbiological and Biomedical Laboratories.

IBC Charter

Learn More

IBC Resources

Learn More

IBC Meeting Schedule

Meetings are free and open to the public. Please contact biosafety@umd.edu for information on attending an IBC meeting.

IBC meetings are typically held the second Wednesday of each month. Project registrations submitted prior to the 15th of the month will be reviewed at the next month's IBC meeting. Amendments to previously approved project registrations, and other minor changes (i.e. room changes, personnel updates) submitted prior to the 25th of the month will be reviewed at the next month's IBC meeting. See the 2021 IBC Committee Calendar for details. 

Projects and amendments may be submitted at https://umd.bioraft.com.

Current Schedule:

Deadline for Protocol Submission

IBC Meeting

July 15

August 10, 2022

August 15

September 14, 2022

September 15

October 12, 2022

October 15

November 9, 2022

November 15

December 14, 2022

December 15

January 11, 2023

January 15

February 8, 2023

February 15

March 8, 2023

March 15

April 12, 2023

 

Back to Top